Nathan Lawrentschuk

Dec 19, 2024 | mdpi.com | Nathan Lawrentschuk

1. IntroductionRadiation therapy is a widely accepted treatment for localised and advanced prostate cancer, with the use of radiation for localised prostate cancer first reported in 1909 [1]. In contrast to this, established historical principles regarding the radioresistance of renal cell carcinoma (RCC) have been recently overturned by new advances in radiation planning and delivery, extending its application to localised and metastatic RCC in this rapidly evolving field of study.

Sep 20, 2024 | europeanurology.com | David Chen |Alice Thomson |Elio Mazzone |Marlon Perera |Nathan Lawrentschuk |Shankar Siva | +1 more

Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes aDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia bDepartment of Urology, Austin Hospital, Heidelberg, Australia cSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia dDepartment of Urology,...

Jul 22, 2024 | europeanurology.com | Nathan Lawrentschuk

Choueiri TK, Tomczak P, Park SH, et alTo read this article in full you will need to make a paymentSubscribe to European UrologyReferencesAdjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. N Engl J Med. 385: 683-694Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol.

Jun 14, 2024 | jcp.bmj.com | Jonathan M. O’Brien |Declan Murphy |Nathan Lawrentschuk

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Apr 16, 2024 | bjui-journals.onlinelibrary.wiley.com | Siyu Huang |David Chen |Marlon Perera |Nathan Lawrentschuk

FG Fournier's gangrene FGSI Fournier's Gangrene Severity Index FMS faecal management system FTSG full-thickness skin graft GIQLI Gastrointestinal Quality of Life Index LOS length of hospital stay STSG split-thickness skin graft Introduction Fournier's gangrene (FG) is a life-threatening necrotising fasciitis of the external genitalia and perineum that most commonly affects men [1]. Patients with immune impairment and diabetes are at increased risk of FG [2].